Hashimoto's thyroiditis: From genes to the disease

Current Genomics

Volumn 12, Issue 8, 2011, Pages 576-588

  Zaletel, Katja ^a   Gaberšček, Simona ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Endogenous factors; Environmental factors; Genetic susceptibility; Hashimoto's thyroiditis; Self tolerance; Thyroid destruction

Indexed keywords

ALPHA INTERFERON; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; DEATH RECEPTOR 5; GAMMA INTERFERON; HLA DR3 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2; INTERLEUKIN 4; IODINE; LEVOTHYROXINE; LITHIUM; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 22; POLYCHLORINATED BIPHENYL; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE; THYROID PEROXIDASE ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VITAMIN D RECEPTOR;

3' UNTRANSLATED REGION; ALLELE; ANTIBODY TITER; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; AUTOIMMUNITY; CELL MEDIATED CYTOTOXICITY; CHRONIC HEPATITIS; CYTOKINE PRODUCTION; DENDRITIC CELL; DIETARY INTAKE; DISEASE ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HEPATITIS C; HUMAN; HYPOTHYROIDISM; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; KIDNEY CARCINOMA; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MICROCHIMERISM; NONHUMAN; POSTPARTUM THYROIDITIS; PREGNANCY; PUERPERIUM; REGULATORY T LYMPHOCYTE; REPRODUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE ACTIVATION; TH1 CELL; THYROID DISEASE; X CHROMOSOME INACTIVATION;

EID: 82155203090     PISSN: 13892029     EISSN: 18755488     Source Type: Journal    
DOI: 10.2174/138920211798120763     Document Type: Article

References (170)

1. Zaletel, K. Determinants of thyroid autoantibody production in Hashimoto's thyroiditis. Expert Rev. Clin. Immunol., 2007, 3, 217-223.
2. Hocevar, M.; Auersperg, M.; Stanovnik, L. The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. Eur. J. Surg. Oncol., 1997, 23, 208-210.
3. McLachlan, S.M.; Rapoport, B. Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid, 2004, 14, 510-520.
4. Staii, A.; Kristina, M.; Todorova-Koteva, K.; Glinberg, S.; Jaume, J.C. Hashimoto thyroiditis is more frequent than expected when diagnosed by cytology which uncovers a pre-clinical state. Thyroid Res., 2010, 3, 11-18.
5. Di Tomaso, L.; Battista, S.; Annarita, D.; Sciarra, A.; Morenghi, E.; Roncalli, M. Cracking spaces in Hashimoto thyroiditis are lymphatic and prelymphatic vessels. Am. J. Surg. Pathol., 2010, 34, 1857-1861.
6. Vanderpump, M.P.; Tunbridge, W.M.; French, J.M.; Appleton, D.; Bates, D.; Clark, F.; Grimley Evans, J.; Hasan, D.M.; Rodgers, H.; Tunbridge, F.; Young, E.T. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf)., 1995, 43, 55-68.
7. Aghini-Lombardi, F.; Antonangeli, L.; Martino, E.; Vitti, P.; Maccherini, D.; Leoli, F.; Rago, T.; Grasso, L.; Valeriano, R.; Balestrieri, A.; Pinchera, A. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J. Clin. Endocrinol. Metab., 1999, 84, 561-566.
8. Hollowell, J.G.; Staehling N.W.; Flanders, W.D.; Hannon, W.H.; Gunter, E.W.; Spencer, C.A.; Braverman, L.E. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab., 2002, 87, 489-499.
9. Tunbridge, W.M.; Evered, D.C.; Hall, R.; Appleton, D.; Brewis, M.; Clark, F.; Evans, J.G.; Young, E.; Bird, T.; Smith, P.A. The spectrum of thyroid disease in a community: the Whickham survey. Clin. Endocrinol. (Oxf)., 1977, 7, 481-493.
10. Canaris, G.J.; Manowitz, N.R.; Mayor, G.; Ridgway, E.C. The Colorado thyroid disease prevalence study. Arch. Intern. Med., 2000, 160, 526-534.
11. Kasagi, K.; Takahashi, N.; Inoue, G.; Honda, T.; Kawachi, Y.; Izumi, Y. Thyroid function in Japanese adults as assessed by a general health checkup system in relation with thyroid-related antibodies and other clinical parameters. Thyroid, 2009, 19, 937-944.
12. Hall, R.; Stanbury, J.B. Familial studies of autoimmune thyroiditis. Clin. Exp. Immunol., 1967, 2, 719-725.
13. Aho, K.; Gordin, A.; Sievers, K.; Takala, J. Thyroid autoimmunity in siblings: a population study. Acta. Endocrinol. Suppl. (Copenh)., 1983, 251, 11-15.
14. Phillips, D.I.; Shields, D.C.; Dugoujon, J.M.; Prentice, L.; McGuffin, P.; Ree Smith, B. Complex segregation analysis of thyroid autoantibodies: are they inherited as an autosomal dominant trait? Hum. Hered., 1993, 43, 141-146.
15. Desai, M.P.; Karandikar, S. Autoimmune thyroid disease in childhood: a study of children and their families. Indian Pediatr., 1999, 36, 659-668.
16. Segni, M.; Wood, J.; Pucarelli, I.; Toscano, V.; Toscano, R.; Pasquino, A.M. Clustering of autoimmune thyroid diseases in children and adolescents: a study of 66 families. J. Pediatr. Endocrinol. Metab., 2001, 14, 1271-1275.
17. Marwaha, R.K.; Sen, S.; Tandon, N.; Sahoo, M.; Walia, R.P.; Singh, S.; Ganguly, S.K.; Jain, S.K. Familial aggregation of autoimmune thyroiditis in first-degree relatives of patients with juvenile autoimmune thyroid disease. Thyroid, 2003, 13, 297-300.
18. Villanueva, R.; Greenberg, D.A.; Davies, T.F.; Tomer, Y. Sibling recurrence risk in autoimmune thyroid disease. Thyroid, 2003, 13, 761-764.
19. Dittmar, M.; Libich, C.; Brenzel, T.; Kahaly, G.J. Increased familial clustering of autoimmune thyroid diseases. Horm. Metab. Res., 2011, 43, 200-204.
20. Brix, T.H.: Hansen, P.S.; Kyvik, K.O.; Hegedüs, L. Aggregation of thyroid autoantibodies in first-degree relatives of patients with autoimmune thyroid disease is mainly due to genes: a twin study. Clin. Endocrinol. (Oxf)., 2004, 60, 329-334.
21. Phillips, D.I.; Osmond, C.; Baird, J.; Huckle, A.; Rees-Smith, B. Is birthweight associated with thyroid autoimmunity? A study in twins. Thyroid, 2002, 12, 377-380.
22. Brix, T.H.; Kyvik, K.O.; Hegedüs, L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. Clin. Endocrinol. (Oxf)., 2000, 53, 171-176.
23. Hansen, P.S.; Brix, T.H.; Iachine, I.; Kyvik, K.O.; Hegedüs, L. The relative importance of genetic and environmental effects for the early stages of thyroid autoimmunity: a study of healthy Danish twins. Eur. J. Endocrinol., 2006, 154, 29-38.
24. Brix, T.H.; Hegedüs, L.; Gardas, A.; Banga, J.P.; Nielsen, C.H. Monozygotic twin pairs discordant for Hashimoto's thyroiditis share a high proportion of thyroid peroxidase autoantibodies to the immunodominant region A. Further evidence for genetic transmission of epitopic fingerprints. Autoimmunity, 2011, 44, 188-194.
25. Jacobson, E.M.; Huber, A.; Tomer, Y. The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J. Autoimmun., 2008, 30, 58-62.
26. Tandon, N.; Zhang, L.; Weetman, A.P. HLA associations with Hashimoto's thyroiditis. Clin. Endocrinol. (Oxf)., 1991, 34, 383-386.
27. Bogner, U.; Badenhoop, K.; Peters, H.; Schmieg, D.; Mayr, W.R.; Usadel, K.H.; Schleusener, H. HLA-DR/DQ gene variation in nongoitrous autoimmune thyroiditis at the serological and molecular level. Autoimmunity, 1992, 4, 155-158.
28. Hunt, P.J.; Marshall, S.E.; Weetman, A.P.; Bunce, M.; Bell, J.I.; Wass, J.A.; Welsh, K.I. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin. Endocrinol. (Oxf)., 2001, 55, 491-499.
29. Badenhoop, K.; Schwartz, G.; Walfish, P.G.; Drummond, V.; Usadel, K.H.; Bottazzo, G.F. Susceptibility to thyroid autoimmune disease: molecular analysis of HLA-D region genes identifies new markers for goitrous Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 1990, 71, 1131-1137.
30. Petrone, A.; Giorgi, G.; Mesturino, C.A.; Capizzi, M.; Cascino, I.; Nistico, L.; Osborn, J.; Di Mario, U.; Buzzetti, R. Association of DRB1 04-DQB1 0301 haplotype and lack of association of two polymorphic sites at CTLA-4 gene with Hashimoto's thyroiditis in an Italian population. Thyroid, 2001, 11, 171-175.
31. Wan, X.L.; Kimura, A.; Dong, R.P.; Honda, K.; Tamai, H.; Sasazuki, T. HLA-A and -DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum. Immunol., 1995, 42, 131-136.
32. Honda, K.; Tamai, H.; Morita, T.; Kuma, K.; Nishimura, Y.; Sasazuki, T. Hashimoto's thyroiditis and HLA in Japanese. J. Clin. Endocrinol. Metab., 1989, 69, 1268-1273.
33. Hawkins, B.R.; Lam, K.S.L.; Ma, J.T.C.; Wang, C.; Yeung, R.T.T. Strong association between HLA-DRw9 and Hashimoto's thyroiditis in Southern Chinese. Acta Endocrinol., 1987, 114, 543-546.
34. Kotsa, K.; Watson, P.F.; Weetman, A.P. A CTLA-4 gene polymorphism is associated with both Graves disease and autoimmune hypothyroidism. Clin. Endocrinol. (Oxf)., 1997, 46, 551-554.
35. Akamizu, T.; Sale, M.M.; Rich, S.S.; Hiratani, H.; Noh, J.Y.; Kanamoto, N.; Saijo, M.; Miyamoto, Y.; Saito, Y.; Nakao, K.; Bowden, D.W. Association of autoimmune thyroid disease with microsatellite markers for the thyrotropin receptor gene and CTLA- 4 in Japanese patients. Thyroid, 2000, 10, 851-858.
36. Donner, H.; Braun, J.; Seidl, C.; Rau, H.; Finke, R.; Ventz, M.; Walfish, P.G.; Usadel, K.H.; Badenhoop, K. Codon 17 polymorphism of the cytotoxic T lymphocyte antigen 4 gene in Hashimoto's thyroiditis and Addison's disease. J. Clin. Endocrinol. Metab., 1997, 82, 4130-4132.
37. Nithiyananthan, R.; Heward, J.M.; Allahabadia, A.; Franklyn, J.A.; Gough, S.C. Polymorphism of the CTLA-4 gene is associated with autoimmune hypothyroidism in the United Kingdom. Thyroid, 2002, 12, 3-6.
38. Terauchi, M.; Yanagawa, T.; Ishikawa, N.; Ito, K.; Fukazawa, T.; Maruyama, H.; Saruta, T. Interactions of HLA-DRB4 and CTLA-4 genes influence thyroid function in Hashimoto's thyroiditis in Japanese population. J. Endocrinol. Invest., 2003, 26, 1208-1212.
39. Park, Y.J.; Chung, H.K.; Park, D.J.; Kim, W.B.; Kim, S.W.; Koh, J.J.; Cho BY. Polymorphism in the promoter and exon 1 of the cytotoxic T lymphocyte antigen-4 gene associated with autoimmune thyroid disease in Koreans. Thyroid, 2000, 10, 453-459.
40. Sahin, M.; Gursoy, A.; Erdogan, M.F. Cytotoxic T lymphocyteassociated molecule-4 polymorphism in Turkish patients with Hashimoto thyroiditis. Int. J. Immunogenet., 2009, 36, 103-106.
41. Bicek, A.; Zaletel, K.; Gaberscek, S.; Pirnat, E.; Krhin, B.; Stopar, T.G.; Hojker, S. 49A/G and CT60 polymorphisms of the cytotoxic T-lymphocyte-associated antigen 4 gene associated with autoimmune thyroid disease. Hum. Immunol., 2009, 70, 820-824.
42. Kavvoura, F.K.; Akamizu, T.; Awata, T.; Ban, Y.; Chistiakov, D.A.; Frydecka, I.; Ghaderi, A.; Gough, S.C.; Hiromatsu, Y.; Ploski, R.; Wang, P.W.; Ban, Y.; Bednarczuk, T.; Chistiakova, E.I.; Chojm, M.; Heward, J.M.; Hiratani, H.; Juo, S.H.; Karabon, L.; Katayama, S.; Kurihara, S.; Liu, R.T.; Miyake, I.; Omrani, G.H.; Pawlak, E.; Taniyama, M.; Tozaki, T.; Ioannidis, J.P. Cytotoxic Tlymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis. J. Clin. Endocrinol. Metab., 2007, 92, 3162-3170.
43. Ueda, H.; Howson, J.M.; Esposito, L.; Heward, J.; Snook, H.; Chamberlain, G.; Rainbow, D.B.; Hunter, K.M.; Smith, A.N.; Di Genova, G.; Herr, M.H.; Dahlman, I.; Payne, F.; Smyth, D.; Lowe, C.; Twells, R.C.; Howlett, S.; Healy, B.; Nutland, S.; Rance, H.E.; Everett, V.; Smink, L.J.; Lam, A.C.; Cordell, H.J.; Walker, N.M.; Bordin, C.; Hulme, J.; Motzo, C.; Cucca, F.; Hess, J.F.; Metzker, M.L.; Rogers, J.; Gregory, S.; Allahabadia, A.; Nithiyananthan, R.; Tuomilehto-Wolf, E.; Tuomilehto, J.; Bingley, P.; Gillespie, K.M.; Undlien, D.E.; Rønningen, K.S.; Guja, C.; Ionescu-Tîrgovişte, C.; Savage, D.A.; Maxwell, A.P.; Carson, D.J.; Patterson, C.C.; Franklyn, J.A.; Clayton, D.G.; Peterson, L.B.; Wicker, L.S.; Todd, J.A.; Gough, S.C. Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature, 2003, 423, 506-511.
44. Ban, Y.; Tozaki, T.; Taniyama, M.; Tomita, M.; Ban, Y. Association of a CTLA-4 3' untranslated region (CT60) single nucleotide polymorphism with autoimmune thyroid disease in the Japanese population. Autoimmunity, 2005, 38, 151-153.
45. Ikegami, H.; Awata, T.; Kawasaki, E.; Kobayashi, T.; Maruyama, T.; Nakanishi, K.; Shimada, A.; Amemiya, S.; Kawabata, Y.; Kurihara, S.; Tanaka, S.; Kanazawa, Y.; Mochizuki, M.; Ogihara, T. The association of CTLA4 polymorphism with type 1 diabetes is concentrated in patients complicated with autoimmune thyroid disease: a multicenter collaborative study in Japan. J. Clin. Endocrinol. Metab., 2006, 91, 1087-1092.
46. Tomer, Y.; Greenberg, D.A.; Barbesino, G.; Concepcion, E.; Davies, T.F. CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J. Clin. Endocrinol. Metab., 2001, 86, 1687-1693.
47. Ban, Y.; Davies, T.F.; Greenberg, D.A.; Kissin, A.; Marder, B.; Murphy, B.; Concepcion, E.S.; Villanueva, R.B.; Barbesino, G.; Ling, V.; Tomer, Y. Analysis of the CTLA-4, CD28, and inducible costimulator (ICOS) genes in autoimmune thyroid disease. Genes Immun., 2003, 4, 586-593.
48. Ban, Y.; Greenberg, D.A.; Davies, T.F.; Jacobson, E.; Concepcion, E.; Tomer, Y. Linkage analysis of thyroid antibody production: evidence for shared susceptibility to clinical autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 2008, 93, 3589-3596.
49. Zaletel, K.; Krhin, B.; Gaberscek, S.; Hojker, S. Thyroid autoantibody production is influenced by exon 1 and promoter CTLA-4 polymorphisms in patients with Hashimoto's thyroiditis. Int. J. Immunogenet., 2006, 33, 87-91.
50. Zaletel, K.; Krhin, B.; Gaberscek, S.; Bicek, A.; Pajic, T.; Hojker, S. Association of CT60 cytotoxic T lymphocyte antigen-4 gene polymorphism with thyroid autoantibody production in patients with Hashimoto's and postpartum thyroiditis. Clin. Exp. Immunol., 2010, 161, 41-47.
51. Burn, G.L.; Svensson, L.; Sanchez-Blanco, C.; Saini, M.; Cope, A.P. Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? FEBS Lett., 2011 [Epub ahead of print].
52. Criswell, L.A.; Pfeiffer, K.A.; Lum, R.F.; Gonzales, B.; Novitzke, J.; Kern, M.; Moser, K.L.; Begovich, A.B.; Carlton, V.E.; Li, W.; Lee, A.T.; Ortmann, W.; Behrens, T.W.; Gregersen, P.K. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am. J. Hum. Genet., 2005, 76, 561-571.
53. Kahles, H.; Ramos-Lopez, E.; Lange, B.; Zwermann, O.; Reincke, M.; Badenhoop, K. Sex-specific association of PTPN22 1858T with type 1 diabetes but not with Hashimoto's thyroiditis or Addison's disease in the German population. Eur. J. Endocrinol., 2005, 153, 895-899.
54. Chabchoub, G.; Teixiera, E.P.; Maalej, A.; Ben Hamad, M.; Bahloul, Z.; Cornelis, F.; Ayadi, H. The R620W polymorphism of the protein tyrosine phosphatase 22 gene in autoimmune thyroid diseases and rheumatoid arthritis in the Tunisian population. Ann. Hum. Biol., 2009, 36, 342-349.
55. Ban, Y.; Tozaki, T.; Taniyama, M.; Tomita, M.; Ban, Y. The codon 620 single nucleotide polymorphism of the protein tyrosine phosphatase-22 gene does not contribute to autoimmune thyroid disease susceptibility in the Japanese. Thyroid, 2005, 15, 1115-1118.
56. Dultz, G.; Matheis, N.; Dittmar, M.; Röhrig, B.; Bender, K.; Kahaly, G.J. The protein tyrosine phosphatase non-receptor type 22 C1858T polymorphism is a joint susceptibility locus for immunthyroiditis and autoimmune diabetes. Thyroid, 2009, 19, 143-148.
57. Kordonouri, O.; Hartmann, R.; Badenhoop, K.; Kahles, H.; Ilonen, J. PTPN22 1858T allele is associated with younger age at onset of type 1 diabetes and is not related to subsequent thyroid autoimmunity. Hum. Immunol., 2010, 71, 731-732.
58. Ban, Y.; Tozaki, T.; Taniyama, M.; Nakano, Y.; Ban, Y.; Ban, Y.; Hirano, T. Association of the protein tyrosine phosphatase nonreceptor 22 haplotypes with autoimmune thyroid disease in the Japanese population. Thyroid, 2010, 20, 893-899.
59. Sakai, K.; Shirasawa, S.; Ishikawa, N.; Ito, K.; Tamai, H.; Kuma, K.; Akamizu, T.; Tanimura, M.; Furugaki, K.; Yamamoto, K.; Sasazuki, T. Identification of susceptibility loci for autoimmune thyroid disease to 5q31-q33 and Hashimoto's thyroiditis to 8q23- q24 by multipoint affected sib-pair linkage analysis in Japanese. Hum. Mol. Genet., 2001, 10, 1379-1386.
60. Tomer, Y.; Ban, Y.; Concepcion, E.; Barbesino, G.; Villanueva, R.; Greenberg, D.A.; Davies, T.F. Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am. J. Hum. Genet., 2003, 73, 736-747.
61. Tomer, Y.; Greenberg, D.A.; Concepcion, E.; Ban, Y.; Davies, T.F. Thyroglobulin is a thyroid specific gene for the familial autoimmune thyroid diseases. J. Clin. Endocrinol. Metab., 2002, 87, 404-407.
62. Ban, Y.; Tozaki, T.; Taniyama, M.; Tomita, M.; Ban, Y. Association of a thyroglobulin gene polymorphism with Hashimoto's thyroiditis in the Japanese population. Clin. Endocrinol. (Oxf)., 2004, 61, 263-268.
63. Collins, J.; Heward, J.M.; Carr-Smith, J.; Daykin, J.; Franklyn, J.A.; Gough, S.C. Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J. Clin. Endocrinol. Metab., 2003, 88, 5039-5042.
64. Ban, Y.; Greenberg, D.A.; Concepcion, E.; Skrabanek, L.; Villanueva, R.; Tomer, Y. Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc. Natl. Acad. Sci. U S A, 2003, 100, 15119-15124.
65. Collins, J.E.; Heward, J.M.; Howson, J.M.; Foxall, H.; Carr-Smith, J.; Franklyn, J.A.; Gough, S.C. Common allelic variants of exons 10, 12, and 33 of the thyroglobulin gene are not associated with autoimmune thyroid disease in the United Kingdom. J. Clin. Endocrinol. Metab., 2004, 89, 6336-6339.
66. Maierhaba, M.; Zhang, J.A.; Yu, Z.Y.; Wang, Y.; Xiao, W.X. Quan, Y; Dong, B.N. Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population. Endocrine, 2008, 33, 294-299.
67. Toubi, E.; Shoenfeld, Y. The role of vitamin D in regulating immune responses. Isr. Med. Assoc. J., 2010, 12, 174-175.
68. Ban, Y.; Taniyama, M.; Ban, Y. Vitamin D receptor gene polymorphisms in Hashimoto's thyroiditis. Thyroid, 2001, 11, 607-608.
69. Lin, W.Y.; Wan, L.; Tsai, C.H.; Chen, R.H.; Lee, C.C.; Tsai, F.J. Vitamin D receptor gene polymorphisms are associated with risk of Hashimoto's thyroiditis in Chinese patients in Taiwan. J. Clin. Lab. Anal., 2006, 20, 109-112.
70. Stefanić, M.; Papić, S.; Suver, M.; Glavas-Obrovac, L.; Karner, I. Association of vitamin D receptor gene 3'-variants with Hashimoto's thyroiditis in the Croatian population. Int. J. Immunogenet., 2008, 35, 125-131.
71. Lopez, E.R.; Zwermann, O.; Segni, M.; Meyer, G.; Reincke, M.; Seissler, J.; Herwig, J.; Usadel, K.H.; Badenhoop, K. Eur. J. Endocrinol., 2004, 151, 193-197.
72. Ito, C.; Watanabe, M.; Okuda, N.; Watanabe, C.; Iwatani, Y. Association between the severity of Hashimoto's disease and the functional +874A/T polymorphism in the interferon-gamma gene. Endocr. J., 2006, 53, 473-478.
73. Nanba, T.; Watanabe, M.; Akamizu, T.; Iwatani, Y. The -590CC genotype in the IL4 gene as a strong predictive factor for the development of hypothyroidism in Hashimoto disease. Clin. Chem., 2008, 54, 621-623.
74. Yamada, H.; Watanabe, M.; Nanba, T.; Akamizu, T.; Iwatani, Y. The +869T/C polymorphism in the transforming growth factor beta1 gene is associated with the severity and intractability of autoimmune thyroid disease. Clin. Exp. Immunol., 2008, 151, 379-382.
75. Inoue, N.; Watanabe, M.; Morita, M.; Tomizawa, R.; Akamizu, T.; Tatsumi, K.; Hidaka, Y.; Iwatani, Y. Association of functional polymorphisms related to the transcriptional level of FOXP3 with prognosis of autoimmune thyroid diseases. Clin. Exp. Immunol., 2010, 162, 402-406.
76. Inoue, N.; Watanabe, M.; Nanba, T.; Wada, M.; Akamizu, T.; Iwatani, Y. Involvement of functional polymorphisms in the TNFA gene in the pathogenesis of autoimmune thyroid diseases and production of anti-thyrotropin receptor antibody. Clin. Exp. Immunol., 2009, 156, 199-204.
77. Spencer, C.A.; Hollowell, J.G.; Kazarosyan, M.; Braverman L.E. National Health and Nutrition Examination Survey III thyroidstimulating hormone (TSH)-thyroperoxidase antibody relationships demonstrate that TSH upper reference limits may be skewed by occult thyroid dysfunction. J. Clin. Endocrinol. Metab., 2007, 92, 4236-4240.
78. Lucas, A.; Julián, M.T.; Cantón, A.; Castell, C.; Casamitjana, R.; Martínez-Cáceres, E.M.; Granada, M.L. Undiagnosed thyroid dysfunction, thyroid antibodies, and iodine excretion in a Mediterranean population. Endocrine, 2010, 38, 391-396.
79. Knudsen, N.; Jorgensen, T.; Rasmussen, S.; Christiansen, E.; Perrild, H. The prevalence of thyroid dysfunction in a population with borderline iodine deficiency. Clin. Endocrinol., 1999, 51, 361-367.
80. Pedersen, I.B.; Knudsen, N.; Jørgensen, T.; Perrild, H.: Ovesen, L.; Laurberg, P. Thyroid peroxidase and thyroglobulin autoantibodies in a large survey of populations with mild and moderate iodine deficiency. Clin. Endocrinol., 2003, 58, 36-42.
81. Hoogendoorn, E.H.; Hermus, A.R.; de Vegt, F.; Ross, H.A.; Verbeek, A.L.; Kiemeney, L.A.; Swinkels, D.W.; Sweep, F.C.; den Heijer, M. Thyroid function and prevalence of anti-thyroperoxidase antibodies in a population with borderline sufficient iodine intake: influences of age and sex. Clin. Chem., 2006, 52, 104-111.
82. McCombe, P.A.; Greer, J.M.; Mackay, I.R. Sexual dimorphism in autoimmune disease. Curr. Mol. Med., 2009, 9, 1058-1079.
83. Invernizzi, P.; Miozzo, M.; Selmi, C.; Persani, L.; Battezzati, P.M.; Zuin, M.; Lucchi, S.; Meroni, P.L.; Marasini, B.; Zeni, S.; Watnik, M.; Grati, F.R.; Simoni, G.; Gershwin, M.E.; Podda, M. X chromosome monosomy: a common mechanism for autoimmune diseases. J. Immunol., 2005, 175, 575-578.
84. Larizza, D.; Calcaterra, V.; Martinetti, M. Increased prevalence of autoimmunity in Turner syndrome--influence of age. J. Autoimmun., 2009, 33, 25-30.
85. Brix, T.H.; Knudsen, G.P.; Kristiansen, M.; Kyvik, K.O.; Orstavik, K.H.; Hegedüs, L. High frequency of skewed X-chromosome inactivation in females with autoimmune thyroid disease: a possible explanation for the female predisposition to thyroid autoimmunity. J. Clin. Endocrinol. Metab., 2005, 90, 5949-5953.
86. Ozcelik, T.; Uz, E.; Akyerli, C.B.; Bagislar, S.; Mustafa, C.A.; Gursoy, A.; Akarsu, N.; Toruner, G.; Kamel, N.; Gullu, S. Evidence from autoimmune thyroiditis of skewed X-chromosome inactivation in female predisposition to autoimmunity. Eur. J. Hum. Genet., 2006, 14, 791-797.
87. Yin, X.; Latif, R.; Tomer, Y.; Davies, T.F. Thyroid epigenetics: X chromosome inactivation in patients with autoimmune thyroid disease. Ann. N. Y. Acad. Sci., 2007, 1110, 193-200.
88. Chabchoub, G.; Uz, E.; Maalej, A.; Mustafa, C.A.; Rebai, A.; Mnif, M.; Bahloul, Z.; Farid, N.R.; Ozcelik, T.; Ayadi, H. Analysis of skewed X-chromosome inactivation in females with rheumatoid arthritis and autoimmune thyroid diseases. Arthritis. Res. Ther., 2009, 11, R106.
89. Brix, T.H.; Hansen, P.S.; Kyvik, K.O.; Hegedüs, L. Preliminary evidence of a noncausal association between the X-chromosome inactivation pattern and thyroid autoimmunity: a twin study. Eur. J. Hum. Genet., 2010, 18, 254-257.
90. Guerin, L.R.; Prins, J.R.; Robertson, S.A. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum. Reprod. Update, 2009, 15, 517-535.
91. Weetman, A.P. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat. Rev. Endocrinol., 2010, 6, 311-318.
92. Kämpe, O.; Jansson, R.; Karlsson, F.A. Effects of L-thyroxine and iodide on the development of autoimmune postpartum thyroiditis. J. Clin. Endocrinol. Metab., 1990, 70, 1014-1018.
93. Kuijpens, J.L.; Pop, V.J.; Vader, H.L.; Drexhage, H.A.; Wiersinga, W.M. Prediction of post partum thyroid dysfunction: can it be improved? Eur. J. Endocrinol., 1998, 139, 36-43.
94. Smyth, P.P.; Wijeyaratne, C.N.; Kaluarachi, W.N.; Smith, D.F.; Premawardhana, L.D.; Parkes, A.B.; Jayasinghe, A.; de Silva, D.G.; Lazarus, J.H. Sequential studies on thyroid antibodies during pregnancy. Thyroid, 2005, 15, 474-477.
95. Lazarus, J.H. The continuing saga of postpartum thyroiditis. J. Clin. Endocrinol. Metab., 2011, 96, 614-616.
96. Kokandi, A.A.; Parkes, A.B.; Premawardhana, L.D.; John, R.; Lazarus, J.H. Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J. Clin. Endocrinol. Metab., 2003, 88, 1126-1132.
97. Bianchi, D.W.; Zickwolf, G.K.; Weil, G.J.; Sylvester, S.; DeMaria, M.A. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl. Acad. Sci. U S A, 1996, 93, 705-708.
98. Evans, P.C.; Lambert, N.; Maloney, S.; Furst, D.E.; Moore, J.M.; Nelson, J.L. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood, 1999, 93, 2033-2037.
99. Koopmans, M.; Kremer Hovinga, I.C.; Baelde, H.J.; Harvey, M.S.; de Heer, E.; Bruijn, J.A.; Bajema, I.M. Chimerism occurs in thyroid, lung, skin and lymph nodes of women with sons. J. Reprod. Immunol., 2008, 78, 68-75.
100. Srivatsa, B.; Srivatsa, S.; Johnson, K.L.; Samura, O.; Lee, S.L.; Bianchi, D.W. Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet, 2001, 358, 2034-2038.
101. Klintschar, M.; Schwaiger, P.; Mannweiler, S.; Regauer, S.; Kleiber, M. Evidence of fetal microchimerism in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 2001, 86, 2494-2498.
102. Renne, C.; Ramos Lopez, E.; Steimle-Grauer, S.A.; Ziolkowski, P.; Pani, M.A.; Luther, C.; Holzer, K.; Encke, A.; Wahl, R.A.; Bechstein, W.O.; Usadel, K.H.; Hansmann, M.L.; Badenhoop, K. Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J. Clin. Endocrinol. Metab., 2004, 89, 5810-5814.
103. Klintschar, M.; Immel, U.D.; Kehlen, A.; Schwaiger, P.; Mustafa, T.; Mannweiler, S.; Regauer, S.; Kleiber, M.; Hoang-Vu, C. Fetal microchimerism in Hashimoto's thyroiditis: a quantitative approach. Eur. J. Endocrinol., 2006, 154, 237-241.
104. Brix, T.H.; Hansen, P.S.; Kyvik, K.O.; Hegedüs, L. Aggregation of thyroid autoantibodies in twins from opposite-sex pairs suggests that microchimerism may play a role in the early stages of thyroid autoimmunity. J. Clin. Endocrinol. Metab., 2009, 94, 4439-4443.
105. Strieder, T.G.; Prummel, M.F.; Tijssen, J.G.; Endert, E.; Wiersinga, W.M. Risk factors for and prevalence of thyroid disorders in a cross-sectional study among healthy female relatives of patients with autoimmune thyroid disease. Clin. Endocrinol. (Oxf)., 2003, 59, 396-401.
106. Walsh, J.P.; Bremner, A.P.; Bulsara, M.K.; O'Leary, P.; Leedman, P.J.; Feddema, P.; Michelangeli, V. Parity and the risk of autoimmune thyroid disease: a community-based study. J. Clin. Endocrinol. Metab., 2005, 90, 5309-5312.
107. Bülow Pedersen, I.; Laurberg, P.; Knudsen, N.; Jørgensen, T.; Perrild, H.; Ovesen, L.; Rasmussen, L.B. Lack of association between thyroid autoantibodies and parity in a population study argues against microchimerism as a trigger of thyroid autoimmunity. Eur. J. Endocrinol., 2006, 154, 39-45.
108. Friedrich, N.; Schwarz, S.; Thonack, J.; John, U.; Wallaschofski, H.; Völzke, H. Association between parity and autoimmune thyroiditis in a general female population. Autoimmunity, 2008, 41, 174-180.
109. Sgarbi, J.A.; Kasamatsu, T.S.; Matsumura, L.K.; Maciel, R.M. Parity is not related to autoimmune thyroid disease in a populationbased study of Japanese-Brazilians. Thyroid, 2010, 20, 1151-1156.
110. Heydarian, P.; Ordookhani, A.; Azizi, F. Goiter rate, serum thyrotropin, thyroid autoantibodies and urinary iodine concentration in Tehranian adults before and after national salt iodization. J. Endocrinol. Invest., 2007, 30, 404-410.
111. Gołkowski, F.; Buziak-Bereza, M.; Trofimiuk, M.; Bałdys-Waligórska, A.; Szybinski, Z.; Huszno, B. Increased prevalence of hyperthyroidism as an early and transient side-effect of implementing iodine prophylaxis. Public Health Nutr., 2007, 10, 799-802.
112. Fountoulakis, S.; Philippou, G.; Tsatsoulis, A. The role of iodine in the evolution of thyroid disease in Greece: from endemic goiter to thyroid autoimmunity. Hormones (Athens), 2007, 6, 25-35.
113. Kahaly, G.J.; Dienes, H.P.; Beyer, J.; Hommel, G. Iodide induces thyroid autoimmunity in patients with endemic goitre: a randomised, double-blind, placebo-controlled trial. Eur. J. Endocrinol., 1998, 139, 290-297.
114. Rose, N.R.; Bonita, R.; Burek, C.L. Iodine: an environmental trigger of thyroiditis. Autoimmun. Rev., 2002, 1, 97-103.
115. Burek, C.L.; Talor, M.V. Environmental triggers of autoimmune thyroiditis. J. Autoimmun., 2009, 33, 183-189.
116. Yu, X.; Li, L.; Li, Q.; Zang, X.; Liu, Z. TRAIL and DR5 Promote Thyroid Follicular Cell Apoptosis in Iodine Excess-Induced Experimental Autoimmune Thyroiditis in NOD Mice. Biol. Trace Elem. Res., 2011 [Epub ahead of print].
117. Tomer, Y. Hepatitis C and interferon induced thyroiditis. J. Autoimmun., 2010, 34, J322-326.
118. Barbesino, G. Drugs affecting thyroid function. Thyroid, 2010, 20, 763-770.
119. Baethge, C.; Blumentritt, H.; Berghöfer, A.; Bschor, T.; Glenn, T.; Adli, M.; Schlattmann, P.; Bauer, M.; Finke, R. Long-term lithium treatment and thyroid antibodies: a controlled study. J. Psychiatry Neurosci., 2005, 30, 423-427.
120. Martino, E.; Bartalena, L.; Bogazzi, F.; Braverman, L.E. The effects of amiodarone on the thyroid. Endocr. Rev., 2001, 22, 240-254.
121. Desailloud, R.; Hober, D. Viruses and thyroiditis: an update. Virol. J., 2009, 6, 5.
122. Wasserman, E.E.; Nelson, K.; Rose, N.R.; Rhode, C.; Pillion, J.P.; Seaberg, E.; Talor, M.V.; Burek, L.; Eaton, W.; Duggan, A.; Yolken, R.H. Infection and thyroid autoimmunity: A seroepidemiologic study of TPOaAb. Autoimmunity, 2009, 42, 439-446.
123. de Freitas, C.U.; Grimaldi Campos, R.A.; Rodrigues Silva, M.A.; Panachão, M.R.; de Moraes, J.C.; Waissmann, W.; Roberto Chacra, A.; Maeda, M.Y.; Minazzi Rodrigues, R.S.; Gonçalves Belchor, J.; Oliveira Barbosa, S.; Santos, R.T. Can living in the surroundings of a petrochemical complex be a risk factor for autoimmune thyroid disease? Environ. Res., 2010, 110, 112-117.
124. Langer, P.; Tajtáková, M.; Kocan, A.; Petrík, J.; Koska, J.; Ksinantová, L.; Rádiková, Z.; Ukropec, J.; Imrich, R.; Hucková, M.; Chovancová, J.; Drobná, B.; Jursa, S.; Vlcek, M.; Bergman, A.; Athanasiadou, M.; Hovander, L.; Shishiba, Y.; Trnovec, T.; Seböková, E.; Klimes, I. Thyroid ultrasound volume, structure and function after long-term high exposure of large population to polychlorinated biphenyls, pesticides and dioxin. Chemosphere, 2007, 69, 118-217.
125. Shevach, E.M. From vanilla to 28 flavours: multiple varieties of T regulatory cells. Immunity, 2006, 25, 195-201.
126. Sakaguchi, S.; Yamaguchi, T.; Nomura, T.; Ono, M. Regulatory T cells and immune tolerance. Cell, 2008, 133, 775-787.
127. Baecher-Allan, C.; Wolf, E.; Hafler, D.A. Functional analysis of highly defined, FACS-isolated populations of human regulatory CD4+CD25+T cells. Clin. Immunol., 2005, 115, 10-18.
128. Kong, Y.M.; Morris, G.P.; Brown, N.K.; Yan, Y.; Flynn, J.C.; David, C.S. Autoimmune thyroiditis: a model uniquely suited to probe regulatory T cell function. J. Autoimmun., 2009, 33, 239-246.
129. Watanabe, M.; Yamamoto, N.; Marouka, H.; Tamai, H.; Matsuzuka, F.; Miyauchi, A.; Iwatani, Y. Independent involvement of CD8+CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. Thyroid, 2002, 12, 801-808.
130. Nakano, A.; Watanabe, M.; Iida, T.; Kuroda, S.; Matsuzuka, F.; Miyauchi, A.; Iwatani, Y. Apoptosis-induced decrease of intrathyroidal CD4(+)CD25(+) regulatory T cells in autoimmune thyroid diseases. Thyroid, 2007, 17, 25-31.
131. Baecher-Allan, C.; Wolf, E.; Hafler, D.A. Class II expression identifies functionally distinct human regulatory T cells. J. Immunol., 2006, 176, 4622-4631.
132. Fountoulakis, S.; Vartholomatos, G.; Kolaitis, N.; Frillingos, S.; Philippou, G.; Tsatsoulis, A. Differential expression of Fas system apoptotic molecules in peripheral lymphocytes from patients with Graves' disease and Hashimoto's thyroiditis. Eur. J. Endocrinol., 2008, 158, 853-859.
133. Toda, S.; Nishimura, T.; Yamada, S.; Koike, N.; Yonemitsu, N.; Watanabe, K. et al. Immunohistochemical expression of growth factors in subacute thyroiditis and their effects on thyroid folliculogenesis and angiogenesis in collagen gel matrix culture. J. Pathol., 1999, 188, 415-422.
134. Betteli, E.; Korn, T.; Kuchroo, V.K. Th17: The third member of the effector T cell trilogy. Curr. Opin. Immunol., 2007, 19, 652-657.
135. Akinci, B.; Comlekci, A.; Yener, S.; Bayraktar, F.; Demir, T.; Ali Ozcan, M.; Yuksel, F.; Yesil, S. Hashimoto's thyroiditis, but not treatment of hypothyroidism, is associated with altered TGF-β1 levels. Arch. Med. Res., 2008, 39, 397-401.
136. Guimaraes, V.C.; Quintans, J.; Fisfalen, M.E.; Straus, F.H.; Fields, P.E.; Medeiros-Neto, DeGroot LJ. Immunosupression of thyroiditis. Endocrinology, 1996, 137, 2199-2207.
137. Chen, K.; Wei, Y.; Sharp, G.C.; Braley-Mullen, H. Mechanism of spontaneous resolution versus fibrosis in granulomatous experimental autoimmune thyroiditis. J. Immunol., 2003, 171, 6236-6243.
138. Ajjan, R.A.; Watson, P.F.; Weetman, A.P. Cytokines and thyroid function. Adv. Neuroimmunol., 1996, 6, 359-386.
139. Battifora, M.; Pesce, G.; Paolieri, F.; Fiorino, N.; Giordano, C.; Riccio, A.M.; Torre, G.; Olive, D.; Bagnasco, M. B7.1 costimulatory molecule is expressed on thyroid follicular cells in Hashimoto's thyroiditis, but not in Graves' disease. J. Clin. Endocrinol. Metab., 1998, 83, 4130-4139.
140. Weetman, A.P. Cellular immune responses in autoimmune thyroid disease. Clin. Endocrinol., 2004, 61, 405-413.
141. Ajjan, R.A.; Watson, P.F.; Mcintosh, R.S.; Weetman, A.P. Intrathyroidal cytokine gene expression in Hashimoto's thyroiditis. Clin. Exp. Immunol., 1996, 105, 523-528.
142. Nielsen, C.H.; Hegedüs, L.; Rieneck, K.; Moeller, A.C.; Leslie, R.G.Q.; Bendtzen, K. Production of interleukin (IL)-5 and IL-10 accompanies T helper cell type 1 (Th2) cytokine responses to a major thyroid self-antigen, thyroglobulin, in health and autoimmune thyroid disease. Clin. Exp. Immunol., 2006, 147, 287-295.
143. Nanba, T.; Watanabe, M.; Inoue, N.; Iwatani, Y. Increases of the Th1/Th2 cell ratio in severe Hashimoto's disease and in the proportion of Th17 cells in intractable Graves' disease. Thyroid, 2009, 19, 495-501.
144. Karanikas, G.; Shuetz, M.; Wahl, K.; Paul, M.; Kontur, S.; Pietschmann, P.; Kletter, K.; Dudczak, R.; Willheim, M. Relation of anti-TPO autoantibody titer and T lymphocyte cytokine production patterns in Hashimoto's thyroiditis. Clin. Endocrinol., 2005, 63, 191-196.
145. Nielsen, C.H.; Brix, T.H.; Leslie, R.G.; Hegedüs, L. A role for autoantibodies in enhancement of proinflammatory cytokine responses to a self-antigen, thyroid peroxidise. Clin. Immunol., 2009, 133, 118-127.
146. Figueroa-Vega, N.; Alfonso-Pérez, M.; Benedicto, I.; Sánchez- Madrid, F.; González-Amaro, R.; Marazuela, M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 2010, 95, 953-962.
147. Shi, Y.; Wang, H.; Su, Z.; Chen, J.; Xue, Y.; Wang, S.; Xue, Y.; He, Z.; Yang, H.; Zhou, C.; Kong, F.; Liu, Y.; Yang, P.; Lu, L.; Shao, Q.; Huang, X.; Xu, H. Differentiation imbalance of Th1/Th17 in peripheral blood mononuclear cells might contribute to pathogenesis of Hashimoto's thyroiditis. Scand. J. Immunol., 2010, 72, 250-255.
148. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science, 1995, 267, 1456-1462.
149. Mitsiades, N.; Poulaki, V.; Mitsiades, C.S.; Koutras, D.A.; Chrousos, G.P. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases. Trends Endocrinol. Metab., 2001, 12, 384-390.
150. Nagata, S.; Golstein, P. The Fas death factor. Science, 1995, 267, 1449-1456.
151. Pan, G.; Ni, J.; Wei, Y.F.; Yu, G.; Gentz, R.; Dixit, V.M. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science, 1997, 277, 815-818.
152. Pan, G.; O'Rourke, K.; Chinnaiyan, A.M.; Gentz, R.; Ebner, R.; Ni, J.K.; Dixit, V.M. The receptor for the cytotoxic ligand TRAIL. Science, 1997, 276, 111-113.
153. Wang, S.H.; Bretz, J.D.; Phelps, E.; Mezosi, E.; Arscott, P.L.; Utsugi, S.; Baker Jr, J.R. A unique combination of inflammatory cytokines enhances apoptosis of thyroid follicular cells and transforms nondestructive to destructive thyroiditis in experimental autoimmune thyroiditis. J. Immunol., 2002, 168, 2470-2474.
154. Kawakami, A.; Eguchi, K.; Matsouka, N.; Tsuboi, M.; Kawabe, Y.; Ishikawa, N.; Ito, K.; Nagataki, S. Thyroid-stimulating hormons inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro. Endocrinology, 1996, 137, 3163-3169.
155. Bretz, J.D.; Rymaszewski, M.; Arscott, P.L.; Myc, A.; Ain, K.B.; Thompson, N.W.; Baker, J.R. TRAIL death pathway expression and induction in thyroid follicular cells. J. Biol. Chem., 1999, 274, 23627-23632.
156. Bretz, J.D.; Baker Jr, J.R. Apoptosis and autoimmune thyroid disease: following a TRAIL to thyroid destruction? Clin. Endocrinol., 2001, 55, 1-11.
157. Bretz, J.D.; Arscott, P.L.; Myc, A.; Baker, J.R. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells. J. Biol. Chem., 1999, 274, 25433-25438.
158. Bursch, W.; Oberhammer, F.; Jirtle, R.L.; Askari, M.; Sedivy, R.; Grasl-Kraupp, B.; Purchio, A.F.; Schulte-Hermann, R. Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. Br. J. Cancer, 1993, 67, 531-536.
159. Gartner, R.; Schopohl, D.; Schaefer, S.; Dugrillon, A.; Erdmann, A.; Toda, S.; Bechtner, G. Regulation of transforming growth factor beta-1 messenger ribonucleic acid expression in porcine thyroid follicles in vitro by growth factors, iodine, or deltaiodolactone. Thyroid, 1997, 7, 633-640.
160. Bechtner, G.; Fröschl, H.; Sachse, A.; Schopohl, D.; Gärtner, R. Induction of apoptosis in porcine thyroid follicles by transforming growth factor β1 and epidermal growth factor. Biochimie, 1999, 81, 315-320.
161. Giordano, C.; Stassi, G.; De Maria, R.; Todaro, M.; Richiusa, P.; Papoff, G.; Ruberti, G.; Galluzzo, A. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis. Science, 1997, 275, 960-963.
162. Arscott, P.L.; Baker Jr, J.R. Short analytical review. Apoptosis and thyroiditis. Clin. Immunol. Immunopathol., 1998, 87, 207-217.
163. Mitsiades, N.; Poulaki, V.; Kotoula, V. et al. Fas/Fas ligand upregulation and Bcl-2 down-regulation may be significant in the patogenesis of Hashimoto's thyroiditis. J. Clin. Endocrinol. Metab., 1998, 83, 2199-2203.
164. Fountoulakis, S.; Vartholomatos, G.; Kolaitis, N.; Frillingos, S.; Philippou, G.; Tsatsoulis, A. HLA-DR expressing peripheral T regulatory cells in newly diagnosed patients with different forms of autoimmune thyroid disease. Thyroid, 2008, 18, 1195-1200.
165. Wang, S.H.; Van Antwerp, M.; Kuick, R. Gauger, P.G.; Doherty, G.M.; Fan, Y.Y.; Baker, J.R.; Jr. Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology, 2007, 148, 4844-52.
166. Kaczmarek, E.; Lacka, K.; Jarmolowska-Jurczyszyn, D.; Sidor, A.; Majewski, P. Changes of B and T lymphocytes and selected apopotosis markers in Hashimoto's thyroiditis. J. Clin. Pathol., 2011, [Epub ahead of print].
167. Jublanc, C.; Beaudeux, J.L.; Aubart, F.; Raphael, M.; Chadarevian, R.; Chapman, M.J.; Bonnefont-Rousselot, D.; Bruckert, E. Serum levels of adhesion molecules ICAM-1 and VCAM-1 and tissue inhibitor of metalloproteinases, TIMP-1, are elevated in patients with autoimmune thyroid disorders: relevance to vascular inflammation. Nutr. Metab. Cardiovasc. Dis., 2010, [Epub ahead of print].
168. Jiang, X.; Feng, X.; Li, G.; Zhao, Q.; Yin, H. Differential expression of connexin 43 in human autoimmune thyroid disease. Acta Histochem., 2010, 112, 278-283.
169. Green, L.M.; Lazarus, J.P.; LaBue, M.; Shah, M.M. Reduced cellcell communication in a spontaneous murine model of autoimmune thyroid disease. Endocrinology, 1995, 136, 3611-8.
170. Mitasíková, M.; Lin, H.; Soukup, T.; Imanaga, I.; Tribulová, N. Diabetes and thyroid hormones affect connexin-43 and PKCepsilon expression in rat heart atria. Physiol. Res., 2009, 58, 211-217.